Takeda Pharmaceutical Company Limited
TAKNYSEHealthcare● Active
$15.74
+$0.14(+0.90%)
Market Cap$49.7B
P/E Ratio—
52W High$18.9
52W Low$12.99
Takeda Pharmaceutical Company Limited (TAK) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · TAK · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.598T | $0.406T | $0.473T | $0.554T | $0.875T |
| Net Receivables | $0.880T | $0.725T | $0.698T | $0.682T | $0.724T |
| Inventory | $1.403T | $1.217T | $1.210T | $0.986T | $0.853T |
| Total Current Assets | $3.104T | $2.521T | $2.559T | $2.398T | $2.594T |
| PP&E Net | $2.130T | $1.968T | $1.990T | $1.691T | $1.583T |
| Goodwill | $5.834T | $5.324T | $5.410T | $4.791T | $4.408T |
| Intangible Assets | $3.434T | $3.632T | $4.275T | $4.270T | $3.819T |
| Total Assets | $15.520T | $14.248T | $15.109T | $13.958T | $13.178T |
| Liabilities | |||||
| Short-Term Debt | $0.514T | $0.549T | $0.367T | $0.340T | $0.204T |
| Accounts Payable | $0.493T | $0.308T | $0.320T | $0.307T | $0.296T |
| Total Current Liabilities | $2.440T | $2.507T | $2.313T | $2.482T | $2.146T |
| Long-Term Debt | $4.389T | $3.966T | $4.477T | $4.043T | $4.141T |
| Total Liabilities | $7.712T | $7.312T | $7.835T | $7.603T | $7.494T |
| Stockholders Equity | |||||
| Retained Earnings | $1.061T | $1.188T | $1.391T | $1.541T | $1.480T |
| Total Stockholders Equity | $7.807T | $6.935T | $7.273T | $6.354T | $5.683T |
| Total Liab & Equity(computed) | $15.519T | $14.247T | $15.108T | $13.957T | $13.178T |
| Debt Summary | |||||
| Total Debt | $4.903T | $4.515T | $4.844T | $4.382T | $4.345T |
| Net Debt | $4.305T | $4.130T | $4.386T | $3.849T | $3.496T |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · JPY · T
Explore more Takeda Pharmaceutical Company Limited data
About Takeda Pharmaceutical Company Limited (TAK) Balance Sheet
Takeda Pharmaceutical Company Limited (TAK) balance sheet shows total assets of $15520.14B with cash of $597.63B. Total liabilities are $7711.62B, total debt $4903.01B, and stockholders equity $7807.31B.
Frequently asked questions
TAK · 4 questionsTakeda Pharmaceutical Company Limited has total debt of $4903.01B with net debt of $4305.38B.
TAK total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10